Revance Therapeutics
RVNC
#7076
Rank
HK$3.04 B
Marketcap
HK$29.03
Share price
-2.86%
Change (1 day)
-48.29%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: HK$3.04 Billion

As of November 2024 Revance Therapeutics has a market cap of HK$3.04 Billion. This makes Revance Therapeutics the world's 7076th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$3.04 B-49.48%
2023HK$6.02 B-49.2%
2022HK$11.86 B29.88%
2021HK$9.13 B-37.51%
2020HK$14.62 B120.85%
2019HK$6.62 B13.58%
2018HK$5.82 B-42.61%
2017HK$10.15 B121.88%
2016HK$4.57 B-38.89%
2015HK$7.48 B139.76%
2014HK$3.12 B

End of Day market cap according to different sources

On Nov 23rd, 2024 the market cap of Revance Therapeutics was reported to be:

HK$3.04 Billion
by Nasdaq info icon info icon
HK$3.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$0.81 B-73.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$2.908 T 95,377.96%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$179.10 B 5,780.38%๐Ÿ‡บ๐Ÿ‡ธ USA